348 related articles for article (PubMed ID: 33676555)
1. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.
Lyu L; Zhang S; Deng Y; Wang M; Deng X; Yang S; Wu Y; Dai Z
J Hematol Oncol; 2021 Mar; 14(1):41. PubMed ID: 33676555
[TBL] [Abstract][Full Text] [Related]
2. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
3. circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis.
Yu J; Shen W; Xu J; Gong B; Gao B; Zhu J
Technol Cancer Res Treat; 2020; 19():1533033820950827. PubMed ID: 32938310
[TBL] [Abstract][Full Text] [Related]
4. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.
Foruzandeh Z; Dorabadi DG; Sadeghi F; Zeinali-Sehrig F; Zaefizadeh M; Rahmati Y; Alivand MR
Mol Biol Rep; 2022 Oct; 49(10):9825-9840. PubMed ID: 35534586
[TBL] [Abstract][Full Text] [Related]
5. Progress of non-coding RNAs in triple-negative breast cancer.
Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA-associated ceRNA network involved in HIF-1 signalling in triple-negative breast cancer: circ_0047303 as a potential key regulator.
Darbeheshti F; Mahdiannasser M; Noroozi Z; Firoozi Z; Mansoori B; Daraei A; Bastami M; Nariman-Saleh-Fam Z; Valipour E; Mansoori Y
J Cell Mol Med; 2021 Dec; 25(24):11322-11332. PubMed ID: 34791795
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.
Wang X; Xue B; Zhang Y; Guo G; Duan X; Dou D
Cell Death Dis; 2021 Apr; 12(5):412. PubMed ID: 33875646
[TBL] [Abstract][Full Text] [Related]
8. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
[TBL] [Abstract][Full Text] [Related]
9. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
He R; Liu P; Xie X; Zhou Y; Liao Q; Xiong W; Li X; Li G; Zeng Z; Tang H
J Exp Clin Cancer Res; 2017 Oct; 36(1):145. PubMed ID: 29037220
[TBL] [Abstract][Full Text] [Related]
10. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
[TBL] [Abstract][Full Text] [Related]
12. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
[TBL] [Abstract][Full Text] [Related]
13. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.
Wang Q; Li Z; Hu Y; Zheng W; Tang W; Zhai C; Gu Z; Tao J; Wang H
J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):323-331. PubMed ID: 31776835
[TBL] [Abstract][Full Text] [Related]
14. Systematic characterization of non-coding RNAs in triple-negative breast cancer.
Mei J; Hao L; Wang H; Xu R; Liu Y; Zhu Y; Liu C
Cell Prolif; 2020 May; 53(5):e12801. PubMed ID: 32249490
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
16. Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review.
Wang H; Shan X; Peng Y; Zhou W
Drug Dev Res; 2023 Aug; 84(5):805-814. PubMed ID: 37114737
[TBL] [Abstract][Full Text] [Related]
17. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.
Zou Y; Zheng S; Xiao W; Xie X; Yang A; Gao G; Xiong Z; Xue Z; Tang H; Xie X
Carcinogenesis; 2019 Dec; 40(12):1469-1479. PubMed ID: 31001629
[TBL] [Abstract][Full Text] [Related]
18. CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation.
Chen T; Wang X; Li C; Zhang H; Liu Y; Han D; Li Y; Li Z; Luo D; Zhang N; Zheng M; Chen B; Wang L; Zhao W; Yang Q
Oncogene; 2021 Apr; 40(15):2756-2771. PubMed ID: 33714984
[TBL] [Abstract][Full Text] [Related]
19. CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.
Xiao W; Zheng S; Zou Y; Yang A; Xie X; Tang H; Xie X
Aging (Albany NY); 2019 Dec; 11(24):12043-12056. PubMed ID: 31857500
[TBL] [Abstract][Full Text] [Related]
20. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression.
Kong Y; Yang L; Wei W; Lyu N; Zou Y; Gao G; Ou X; Xie X; Tang H
Epigenomics; 2019 Aug; 11(10):1163-1176. PubMed ID: 31337246
[No Abstract] [Full Text] [Related]
[Next] [New Search]